The Top Master's programme in Nanoscience has been assessed by an international peer review committee, organized by QANU, and their report has now been published and confirmed by the NVAO (Accreditation Organisation of the Netherlands and Flanders). On three standards of the four standards that have to be assessed, the committee has awarded the Master's degree programme the highest possible distinction of "excellent".
The overall summary assessment is also "excellent". The meaning of this epithet is, according to the NVAO rules: "The programme systematically well surpasses the generic quality standards across its entire spectrum and is regarded as an (inter)national example". This is the third time that the Nanoscience programme has received this distinction of "excellent".
The committee writes: "The students of the Master's programme convincingly show that they systematically far exceed the expected level for graduates of a Master's programme." and "Overall, the panel was very impressed by the programme's design and focus, and considers it an internationally unique Master's programme."
The Master's degree programme in Nanoscience started in 2003. The sixteenth cohort of students started in September 2018. So far, more than 110 students have graduated from this degree programme, of whom almost everyone continued towards a PhD.
The Master's programme in Nanoscience is offered in close collaboration with the Zernike Institute for Advanced Materials, a leading international research centre in this field. It belongs to the Times Higer Education top 20 of best materials research institutes in the world. It unites around 300 leading researchers.
The University of Groningen (UG) will soon have a new Bachelor’s degree programme on offer: Biomedical Engineering.
If you are a black-tailed godwit (Limosa limosa limosa), your biannual migrations over the Sahara desert may prove fatal. Black-tailed godwits that breed in the Netherlands mostly spend their winters in West Africa, and so they fly over the Sahara twice...
Parkinson’s disease causes brain cells that produce the neurotransmitter dopamine to die. But where does the disease start? Evidence suggests that a failure of the brain’s immune system may be the root cause of the disease.